Cohance Lifesciences Limited
Promoter holding in Cohance Lifesciences Limited was 57.49% in Jun 2026, unchanged from the previous quarter. Since Sep 2024 it has risen 7.39 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 57.49%=0.00 | 42.51%=0.00 |
| Mar '26 | 57.49%=0.00 | 42.51%=0.00 |
| Dec '25 | 57.49%=0.00 | 42.51%=0.00 |
| Sep '25 | 57.49%▼8.92 | 42.51%▲8.92 |
| Jun '25 | 66.41%=0.00 | 33.59%=0.00 |
| Mar '25 | 66.41%▲16.31 | 33.59%▼16.31 |
| Dec '24 | 50.10%=0.00 | 49.90%=0.00 |
| Sep '24 | 50.10%=0.00 | 49.90%=0.00 |
Trend
- Over a longer period, promoter holding went from 60.00% in Sep 2021 to 57.49% in Jun 2026, down 2.51 points.
- Of the last 8 quarterly changes on record, promoter holding rose in 1, fell in 1 and stayed the same in 6.
- The largest quarterly change was a rise of 16.31 points in the quarter to Mar 2025.
Compared with similar companies
Promoter holding in Cohance Lifesciences Limited is higher than 55% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Cohance Lifesciences Limited | 57.49% |
| Shilpa Medicare Limited | 40.13% |
| Caplin Point Laboratories Limited | 70.57% |
| Pfizer Limited | 63.92% |
| Alivus Life Sciences Limited | 74.87% |
| OneSource Specialty Pharma Limited | 30.48% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Cohance Lifesciences Limited's promoter holding?
Promoters held 57.49% of Cohance Lifesciences Limited as of 30 Jun 2026, and the public held 42.51%.
Has Cohance Lifesciences Limited's promoter holding increased?
No, it was unchanged in the quarter to Jun 2026.
Are any promoter shares of Cohance Lifesciences Limited pledged?
No promoter shares are recorded as pledged.
How has Cohance Lifesciences Limited's promoter holding changed over the years?
Over a longer period, promoter holding went from 60.00% in Sep 2021 to 57.49% in Jun 2026, down 2.51 points.
How does Cohance Lifesciences Limited's promoter holding compare with similar companies?
Promoter holding in Cohance Lifesciences Limited is higher than 55% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.